Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 100 publications
Suppression of de novo lipogenesis and dietary PUFA supplementation inhibit prostate cancer progression.
Journal: bioRxiv : the preprint server for biology
Published: April 03, 2026
Targeted proteomics for the detection of androgen receptor variants in preclinical models of castration-resistant prostate cancer.
Journal: Clinical proteomics
Published: February 12, 2026
Androgen receptor splice variant 7 expression levels distinguish AR-mutated from nonmutated metastatic castration-resistant prostate cancers.
Journal: The Journal of clinical investigation
Published: July 23, 2025
Unraveling the Global Proteome and Phosphoproteome of Prostate Cancer Patient-Derived Xenografts.
Journal: Molecular cancer research : MCR
Published: November 21, 2023
A Compound That Inhibits Glycolysis in Prostate Cancer Controls Growth of Advanced Prostate Cancer.
Journal: Molecular cancer therapeutics
Published: August 18, 2023
Unraveling the Global Proteome and Phosphoproteome of Prostate Cancer Patient-Derived Xenografts.
Journal: bioRxiv : the preprint server for biology
Published: August 14, 2023
The Prostate Cancer Active Lifestyle Study (PALS): A randomized controlled trial of diet and exercise in overweight and obese men on active surveillance.
Journal: Cancer
Published: July 29, 2023
A Compound that Inhibits Glycolysis in Prostate Cancer Controls Growth of Advanced Prostate Cancer.
Journal: bioRxiv : the preprint server for biology
Published: July 18, 2023
Thio-2 Inhibits Key Signaling Pathways Required for the Development and Progression of Castration-resistant Prostate Cancer.
Journal: Molecular cancer therapeutics
Published: June 08, 2023
Development and Validation of a New BAG-1L-Specific Antibody to Quantify BAG-1L Protein Expression in Advanced Prostate Cancer.
Journal: Laboratory investigation; a journal of technical methods and pathology
Published: March 28, 2023
Androgen receptor splice variants drive castration-resistant prostate cancer metastasis by activating distinct transcriptional programs.
Journal: The Journal of clinical investigation
Published: January 06, 2023
Last Updated: 09/26/2026